**Complementary Therapies**

[29] Oriji VK. Laparoscopic ovarian drilling versus medical treatment of in management of clomiphene citrate resistant polycystic ovary syndrome. World Journal of Laparoscopic

[30] Saleh AM, Khalil HS. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica. 2004;83(7):614-621. DOI:

Surgeries. 2010;3(2):99-102

88 Debatable Topics in PCOS Patients

10.1111/j.0001-6349.2004.00481.x

**Chapter 7**

**Provisional chapter**

**Complementary Therapy with Traditional Chinese**

Polycystic ovarian syndrome (PCOS) is a common, heterogeneous, complex, endocrinopathic condition that causes menstrual dysfunction and infertility in women. Traditional Chinese medicine (TCM) has been widely used for PCOS in Far-East countries for thousands of years. There are significant advantages in treating PCOS with TCM. This chapter

**Keywords:** complementary and alternative therapy, traditional Chinese medicine,

Polycystic ovarian syndrome (PCOS) is characterized by endocrine and ovarian disorders that affect quality of life in women of reproductive age. In 1935, PCOS was first described by Stein and Leventhal with a description of seven women suffering from amenorrhea, hirsutism, and enlarged ovaries with multiple cysts [1, 2]. Some different criteria about the National Institute of Health (NIH), Rotterdam criteria, Androgen Excess Society and Polycystic Ovary

aims to investigate the current developments in TCM therapy for PCOS.

polycystic ovarian syndrome, acupuncture, moxibustion

Syndrome Society guidelines (AE-PCOS) are shown in **Table 1** [3–8].

**Complementary Therapy with Traditional Chinese** 

DOI: 10.5772/intechopen.71654

© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,

© 2018 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

and reproduction in any medium, provided the original work is properly cited.

Globally, PCOS affects 5–20% of women of reproductive age [9]. One report summarized the incidence of PCOS as 6–13% in Hispanic women, 3–9% in African American women, and 2–9% in Asian women [10]. The prevalence of PCOS in different geographical regions ranges from

**Medicine for Polycystic Ovarian Syndrome**

**Medicine for Polycystic Ovarian Syndrome**

Yen-Nung Liao, Wen-Long Hu and Yu-Chiang Hung

Yen-Nung Liao, Wen-Long Hu and Yu-Chiang Hung

Additional information is available at the end of the chapter

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/intechopen.71654

**Abstract**

**1. Introduction**

**1.2. Epidemiology**

**1.1. Definition**

**Provisional chapter**
